Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

ICON makes two senior appointments

May 21, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRO, ICON, appointment

ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research. …
Appointment

GSK buys more of Theravance

May 18, 2012 Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance

GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …
News
screen_shot_2012-05-18_at_09

Teva re-elects Chairman of the Board

May 18, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frost, Teva

Teva has announced that its Board of Directors has unanimously voted to re-elect Dr Phillip Frost as Chairman of the …
Appointment

Medivir appoints commercial executive vice president

May 17, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Juserius, Medivir

Research-based speciality firm Medivir has appointed Henric Juserius to be the new head of the company’s commercial activities.  Juserius who …
Appointment
Nexavar image

Torisel fails in head-to-head study with Nexavar

May 16, 2012 Research and Development, Sales and Marketing Bayer, Nexavar, Pfizer, Torisel, inlyta, rcc

Pfizer’s kidney cancer drug Torisel has failed to best Bayer’s Nexavar in a head-to-head trial.  The Phase III study was …
News

Pharma funds drug discovery partnership

May 16, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dundee, MRC, drug discovery, funding, partnerships, pharma

Half a dozen pharma firms are contributing £14.4 million to work by Dundee University and the Medical Research Council (MRC) on …
News
Erbitux image

Merck KGaA’s colon cancer drug fails trial

May 16, 2012 Research and Development, Sales and Marketing Erbitux, Merck KGaA, Merck Serono, colon cancer

Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial.  …
News

Capturing the Brazilian pharma opportunity

May 16, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma

 Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …
Feature

Merck KGaA sets out savings target as staff threaten to strike

May 15, 2012 Research and Development, Sales and Marketing Merck KGaA, R&D, Serono, cuts

Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …
News

CoreLab Partners collaborates at industry conferences worldwide

May 15, 2012 Research and Development

Princeton, NJ May 15, 2012 – CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and …
News
Press release
GSK picture

GlaxoSmithKline to acquire Cellzome for £61 million

May 15, 2012 Research and Development, Sales and Marketing Cellzome, Domantis, GSK, R&D

GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company.  GSK will acquire those shares …
News

Synthetic Biologics appoints Carol Reed

May 15, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Carol Reed, Synthetic

Synthetic Biologics has appointed Carol Reed as senior vice president of Clinical & Regulatory Affairs. In this position Reed will …
Appointment

New Quad HIV pill on track for FDA approval

May 14, 2012 Research and Development, Sales and Marketing BMS, Compera, FDA, Gilead, HIV, The Quad

Gilead Sciences’ four-in-one HIV pill has been given the thumbs up by an FDA advisory group.  The US regulator is …
News
FDA picture

Obesity drugs vie for approval as FDA panel backs lorcaserin

May 14, 2012 Research and Development, Sales and Marketing Arena, Eisai, FDA, Qnexa, lorcaserin, obesity

An FDA panel has recommended Arena’s obesity drug lorcaserin, setting up a showdown with Vivus’ Qnexa. Qnexa was recommended by an FDA panel …
News

Gamification and online communities – what can pharma do?

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Gamification, Syrum, digital marketing

Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This new …
Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026